首頁 > 市場調查報告書 > 製藥

北美色素沉著過度障礙治療市場預測至 2030 年 - 區域分析 - 按治療類型、病情和最終用戶

市場調查報告書

商品編碼

1597094

北美色素沉著過度障礙治療市場預測至 2030 年 - 區域分析 - 按治療類型、病情和最終用戶

North America Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 84 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美色素沉著過度障礙治療市場估值為16.9483億美元，預計2030年將達到30.2873億美元；預計2022年至2030年複合年成長率為7.5%。

黃褐斑盛行率的上升推動了北美色素沉著過度疾病治療市場

黃褐斑是最主要的色素沉著過度病症之一，其特徵是對稱的淺色至深色泥褐色斑疹，邊界位於臉部，特別是下巴、上唇、鼻子、前額和臉頰。它在女性和膚色較深的人中普遍存在。顴骨、下顎和臉部中央的臨床特徵在黃褐斑中很常見。陽光照射、荷爾蒙變化、懷孕、遺傳因素、化妝品和藥物都與黃褐斑的發生有關。各種研究估計，一般人群中黃褐斑的總體盛行率在 1% 到 50% 之間。 55-64% 的黃褐斑病例報告有相同病症的家族史。此外，據報道，東亞和西班牙裔以及具有高 Fitzpatrick 皮膚光型（IV 至 VI）的患者的盛行率更高；居住在受到強烈紫外線輻射的地方的人的這一比例也更高。

懷孕是黃褐斑的另一個常見原因。這種情況也會影響服用口服避孕藥和荷爾蒙的女性。雌激素、黃體素和黑色素細胞刺激激素水平通常在懷孕晚期升高，這可能是一個因素。根據美國國家生物技術資訊中心（NCBI）2023年8月的數據，黃褐斑在育齡期更為常見，青春期之前很少發生； 15-50%的孕婦會出現這種情況，盛行率從1.5%到33%不等，取決於不同地區的人口。因此，黃褐斑盛行率的激增引發了對色素沉著過度治療的需求。

北美色素沉著過度疾病治療市場概述

北美色素沉著過度症治療市場分為美國、加拿大和墨西哥。 2023 年，美國佔據北美最大的色素沉著過度障礙治療市場佔有率。該國的亞洲人口和非洲人，這也可能導致2050 年左右，少數族群轉向菲茨帕特里克III、IV、V 和VI 皮膚類型。具體而言，西班牙裔人口預計將成為美國成長最快的人口群體之一，預計將從 2014 年的 5,500 萬人成長到 2060 年的 1.19 億。

過去 10 年來，美國的美容手術數量顯著增加。根據國際整形外科醫師協會 (ISAPS) 的數據，與 2020 年相比，2021 年全球非手術美容手術數量增加了 19.9%。強烈脈衝光(IPL) 治療是前5 名的微創美容手術之一，2020 年美國進行了約827,000 例IPL 手術。市場。 2023 年 3 月，美國食品藥物管理局 (FDA) 批准 Candela Corporation 的 PicoWay 雷射治療牛奶咖啡、黃褐斑、雀斑和太田痣。此前，該雷射系統已被批准用於治療良性色素病變、痤瘡疤痕、皺紋和去除紋身等適應症。

因此，民族和種族多樣性的不斷成長，以及藥妝、化學換膚、冷凍療法、光或雷射療法等非侵入性醫療美容手術的發展等因素促進了美國色素沉著過度疾病治療市場的成長。

北美色素沉著過度疾病治療市場收入及 2030 年預測（百萬美元）

北美色素沉著過度疾病治療市場細分

北美色素沉著過度障礙治療市場按治療類型、病情、最終用戶和國家分類。

根據治療類型，北美色素沉著過度症治療市場分為藥妝、光或雷射療法、微晶煥膚、化學換膚、冷凍療法等。 2022年，藥妝領域佔據最大的市場佔有率。

根據病情，北美色素沉著過度障礙治療市場分為黃褐斑、日光性雀斑、發炎後色素沉著等。黃褐斑細分市場在 2022 年佔據最大的市場。

根據最終用戶，北美色素沉著過度障礙治療市場分為醫院、皮膚科中心等。 2022 年，醫院細分市場佔據最大的市場佔有率。

按國家/地區分類，北美色素沉著過度障礙治療市場分為美國、加拿大和墨西哥。 2022 年，美國在北美色素沉著過度障礙治療市場佔有率中佔據主導地位。

艾伯維公司（AbbVie Inc）、拜耳公司（Bayer AG）、高德瑪公司（Galderma SA）、歐萊雅公司（L'OREAL SA）、路創力有限公司（Lutronic Co Ltd）、歐邦琪藥妝有限責任該公司（Obagi Cosmeceuticals LLC）和維維亞製藥公司（Vivier Pharma Inc）是北美色素沉著過度障礙治療市場的一些領先公司。

Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin, upper lip, nose, forehead, and cheeks. It is prevalent among women and those with darker complexion. Malar, mandibular, and centrofacial clinical features are common in melasma. Sun exposure, hormonal variations, pregnancy, hereditary factors, cosmetics, and medicines have all been linked to the development of melasma. Various studies have estimated that the overall prevalence of melasma in the general population ranges from 1% to 50%. 55-64% of melasma cases have reported a family history of the same condition. Moreover, a greater prevalence is reported in individuals of East Asian and Hispanic origins as well as in patients with high Fitzpatrick skin phototypes (IV to VI); it is also higher in individuals living in locations that receive intense UV radiation.

Pregnancy is another common cause of melasma. This condition also impacts women taking oral contraceptives and hormones. Estrogen, progesterone, and melanocyte-stimulating hormone levels normally rise during the third trimester of pregnancy, which may be a factor. According to the National Center for Biotechnology Information (NCBI) in August 2023, melasma is more common in reproductive years, and it rarely occurs before puberty; the condition occurs in 15-50% of pregnant women, and its prevalence ranges from 1.5% to 33%, depending on the population in a different region. Therefore, an upsurge in melasma prevalence triggers the demand for hyperpigmentation treatments.

North America Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in North America is segmented into the US, Canada, and Mexico. The US held the largest North America hyperpigmentation disorder treatment market share in 2023. According to the Skin of Color Update 2024 (a dermatology conference), the demographics of the US are evolving with the growth of ethnic and racial diversity driven by international migration of Hispanics, Asian populations, and Africans in the country, which is also likely to lead to a minority-majority shift around the year 2050 toward individuals of Fitzpatrick III, IV, V, and VI skin types. Specifically, the Hispanic population is expected to be among the fastest-growing demographic groups in the US, with estimated growth from 55 million in 2014 to 119 million in 2060. A dark skin type is more prone to hyperpigmentation disorders.

The number of aesthetic procedures in the US has increased significantly over the last 10 years. According to the International Society of Plastic Surgeons (ISAPS), the number of nonsurgical aesthetic procedures rose by 19.9% in 2021 compared to 2020 globally. Intense pulsed light (IPL) treatment is among the top 5 minimally invasive cosmetic procedures, and ~827,000 IPL procedures were performed in the US in 2020. Thus, technological advancements in noninvasive procedures are likely to further benefit the hyperpigmentation disorder treatment market in the US. In March 2023, the US Food and Drug Administration (FDA) cleared Candela Corporation's PicoWay laser to treat cafe au lait, melasma, lentigines, and Nevus of Ota. Previously, the laser system was approved for the treatment of benign pigmented lesions, acne scarring, wrinkles, and tattoo removal, among other indications.

Therefore, factors such as the growing ethnic and racial diversity, and the development of noninvasive medical aesthetic procedures such as cosmeceutics, chemical peels, cryotherapy, light, or laser therapy contribute to the hyperpigmentation disorder treatment market growth in the US.

North America Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Hyperpigmentation Disorder Treatment Market Segmentation

The North America hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

Based on treatment type, the North America hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.

Based on condition, the North America hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.

Based on end user, the North America hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.

By country, the North America hyperpigmentation disorder treatment market is segmented into the US, Canada, and Mexico. The US dominated the North America hyperpigmentation disorder treatment market share in 2022.

AbbVie Inc, Bayer AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Vivier Pharma Inc are some of the leading companies operating in the North America hyperpigmentation disorder treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Melasma
- 4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
- 4.2.1 High Cost of Treatments
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Use of Ablative Lasers
- 4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:

5. Hyperpigmentation Disorder Treatment Market - North America Analysis

5.1 North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030

6. North America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

6.1 Cosmeceutical
- 6.1.1 Overview
- 6.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
- 6.2.1 Overview
- 6.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
- 6.3.1 Overview
- 6.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
- 6.4.1 Overview
- 6.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
- 6.5.1 Overview
- 6.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Hyperpigmentation Disorder Treatment Market Analysis - by Condition

7.1 Melasma
- 7.1.1 Overview
- 7.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
- 7.2.1 Overview
- 7.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
- 7.3.1 Overview
- 7.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Hyperpigmentation Disorder Treatment Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
- 8.2.1 Overview
- 8.2.2 Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Hyperpigmentation Disorder Treatment Market - Country Analysis

9.1 North America Hyperpigmentation Disorder Treatment Market
- 9.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 US
  - 9.1.1.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.4 Canada
  - 9.1.1.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.6 Mexico
  - 9.1.1.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

10. Hyperpigmentation Disorder Treatment Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 AbbVie Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Galderma SA
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Bayer AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Lutronic Co Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 L'OREAL S.A.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Pierre Fabre SA
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Vivier Pharma Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Number of Laser-Based Nonsurgical Procedures Performed, 2020
Table 7. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 8. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 9. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 10. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 11. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 12. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 14. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 15. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 16. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 17. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 18. Glossary of Terms, Hyperpigmentation Disorder Treatment Market

List Of Figures

Figure 1. North America Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 6. Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 13. Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 18. Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 22. North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Hyperpigmentation Disorder Treatment Market